CompositesWorld

Fibre Glast 2001 laminating epoxy balances easy handling, professional-grade performance

The novel epoxy resin formation, targeting composites fabrication, improves finish clarity, enhances toughness and is cold ...
CompositesWorld

The future is composite: Innovation, resilience and human experience

CAMX 2025 showcased the power of collaboration and purposeful innovation, a clear reminder that the composites industry is all about human potential.

MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody sonelokimab

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 ...
Taiwan News

MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 program ...
RMD Open

Decreased GPR55 expression links B-cell activation and vascular remodelling in atherosclerosis in patients with early rheumatoid arthritis

Objective Inflammation and repair responses may be involved in atherosclerosis in rheumatoid arthritis (RA), although ...